Rivastigmine Film, Extended Release shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-09-18 · last update 2026-09-18
Manufacturers: Mylan Pharmaceuticals Inc., a Viatris Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted 09/18/2026 Updated 09/18/2026 Discontinued 09/18/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)